The world’s largest drugmaker, Pfizer Inc, is voluntarily recalling three intravenous (IV) drugs manufactured by Indian drugmaker Claris Lifesciences from the US market. Of these, Metronidazole and Ciprofloxacin injections are IV antibiotics used to treat infections. The third, Ondansetron injection, is used in nausea and vomiting associated with chemotherapy or surgery.
Additionally, Pfizer has also decided to halt distribution of all sterile injectable products in intravenous bags licensed from Claris to ensure patient safety. Pfizer, which started distributing these products in the US this year, had entered into a licensing agreement with Claris in May 2009 to market 15 injectables in multiple geographies. However, industry sources believe that Claris has till now supplied only the three above-mentioned drugs to Pfizer as part of the arrangement. Experts feel that a single incident such as this may not make the well thought strategy of big pharma companies to collaborate with generic firms. ...............& more
No comments:
Post a Comment